Your browser doesn't support javascript.
loading
First-line treatment with ceftriaxone for Neisseria gonorrhoeae infection less likely to be prescribed to patients with a penicillin allergy label: a retrospective audit of medical records.
Durban, E; English, K; Evans, R; Martin, S.
Afiliación
  • Durban E; Research School of Biology, Australian National University, Canberra, ACT, Australia.
  • English K; Canberra Sexual Health Centre, Canberra Health Services, Garran, ACT, Australia.
  • Evans R; Canberra Sexual Health Centre, Canberra Health Services, Garran, ACT, Australia.
  • Martin S; Canberra Sexual Health Centre, Canberra Health Services, Garran, ACT, Australia; and School of Medicine and Psychology, Australian National University, Canberra, ACT, Australia.
Sex Health ; 212024 Jul.
Article en En | MEDLINE | ID: mdl-39008622
ABSTRACT
Background Gonorrhoea notifications have increased substantially in Australia over the past decade. Neisseria gonorrhoeae is already highly resistant to several antibiotics and so, alternatives to first-line treatment are generally strongly discouraged. The penicillin allergy label (AL) on patient medical records has previously been shown to influence prescribing practices, to the detriment of best-practice management and antimicrobial stewardship. This study aimed to understand how the penicillin AL influences antibiotic selection for gonorrhoea treatment at Canberra Sexual Health Centre. Methods A retrospective chart audit of gonorrhoea cases treated at Canberra Sexual Health Centre between January 2020 and October 2023 (n =619 patients, n =728 cases). Antibiotic selection was assessed according to penicillin AL status. Ceftriaxone selection was assessed according to penicillin allergy severity reported in the medical records and as determined using a validated antibiotic allergy assessment tool. Results Cases with a penicillin AL were more likely to receive antibiotics other than ceftriaxone (n =7/41, 17.1%) than cases without the label (n =8/687, 1.2%, P n =28/41, 68.3%) to apply the assessment tool. Those reported as low-severity in the records were more likely to receive ceftriaxone (n =21/22, 95.5%) than those reported as moderate-high (n =7/11, 63.6%) or unreported (n =6/8, 0.75%). Conclusions Treatment of gonorrhoea in outpatient settings requires an understanding of penicillin allergy, and the ability to quickly and accurately identify penicillin-AL patients who can safely tolerate ceftriaxone. Institutionally endorsed penicillin allergy de-labelling protocols and access to easy-to-navigate prescribing advice within national sexually transmitted infection management guidelines would support this.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Penicilinas / Ceftriaxona / Gonorrea / Hipersensibilidad a las Drogas / Antibacterianos Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Sex Health Asunto de la revista: DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Penicilinas / Ceftriaxona / Gonorrea / Hipersensibilidad a las Drogas / Antibacterianos Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Oceania Idioma: En Revista: Sex Health Asunto de la revista: DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia